CDT Equity Inc. (CDT) vs Matinas Biopharma Holdings, Inc. (MTNB)

CDT Equity Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. CDT Equity Inc. and Matinas Biopharma Holdings, Inc. are of similar size ($2.4M and $2.4M). Across the 9 metrics below, CDT Equity Inc. leads on 7 and Matinas Biopharma Holdings, Inc. on 2.

Valuation

Metric CDT MTNB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.24 11.47
P/B n/m 0.57 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 0.05 10.73
Earnings yield 167,728,033.38% (731.25%) (28.84%)
Free cash flow yield (278,822.70%) (595.22%) (23.03%)

Profitability

Metric CDT MTNB Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.68%) (154.28%) (57.72%)
Return on assets (55.16%) (98.53%) (49.22%)
Return on invested capital (21.28%) (419.27%) 0.00%

Growth

Metric CDT MTNB Biotechnology median
Revenue growth (TTM) — 2,139.41% 5.64%
EPS growth (last fiscal year) 98.09% 59.84% —
Revenue growth, 5-year CAGR — 55.69% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 0.85 4.73
Net debt to EBITDA 0.05 0.62 0.96

Dividend

Metric CDT MTNB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CDT MTNB Biotechnology median
Market cap 2.41m 2.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack